Trial Profile
An Open-Label Study of CC-10004 [apremilast] for Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Mar 2012
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Prostatitis
- Focus Therapeutic Use
- 08 Mar 2012 Actual patient number (18) added as reported by ClinicalTrials.gov.
- 04 Apr 2011 Actual end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 04 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.